The automated immunoassay analyzers market size has grown rapidly in recent years. It will grow from $23.09 billion in 2025 to $26.39 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to expansion of centralized clinical laboratories, growth in routine immunoassay testing volumes, increasing disease screening programs, early automation of laboratory workflows, adoption of immunoassay systems for infectious disease monitoring.
The automated immunoassay analyzers market size is expected to see rapid growth in the next few years. It will grow to $44.93 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to rising chronic and endocrine disorder testing needs, growing oncology and biomarker testing, demand for faster turnaround diagnostic results, increasing integration of automated platforms in research labs, expansion of pharmaceutical and biotech r&d testing applications. Major trends in the forecast period include growing demand for high-throughput diagnostic testing, increased adoption in infectious disease and endocrinology testing, expansion of automated testing in research and academic laboratories, rising utilization in therapeutic drug monitoring and oncology diagnostics, standardization of laboratory workflows to improve testing efficiency.
The increasing number of hospitals is expected to propel the growth of the automated immunoassay analyzers market going forward. Hospitals are healthcare institutions that provide medical, surgical, and diagnostic services to patients requiring routine treatment or emergency care, supported by specialized infrastructure and healthcare professionals. The global rise in the number of hospitals is driven by growing healthcare demand from expanding and aging populations, along with increased investments in healthcare infrastructure. Automated immunoassay analyzers support hospitals by enabling high-throughput, accurate, and rapid diagnostic testing for a wide range of diseases, improving clinical efficiency and patient outcomes. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the number of hospitals in the United States increased to 6,129 in 2023 from 6,093 in 2022, reflecting a 0.59% growth. Therefore, the increasing number of hospitals is driving the growth of the automated immunoassay analyzers market.
Leading companies in the automated immunoassay analyzer market are focusing on developing advanced products, such as compact immunoassay analyzers, to gain a competitive edge. These compact devices are designed for conducting immunoassay tests to detect specific biomarkers in biological samples and offer convenience and efficiency in various healthcare settings, especially where space and mobility are constraints. For instance, in July 2023, Siemens Healthineers, a Germany-based healthcare company, introduced the Atellica CI Analyzer. This compact system combines immunoassay and clinical chemistry testing into a single platform, addressing the growing demand for versatile and efficient testing solutions. The Atellica CI Analyzer features random access sampling, micro-volume aspiration, and automated maintenance and quality control scheduling to enhance the consistency and predictability of sample processing times.
In July 2024, Roche, a Switzerland-based provider of diagnostics, pharmaceutical products, and point-of-care testing solutions, acquired LumiraDx’s point-of-care technology for an undisclosed amount. With this acquisition, Roche aims to strengthen and decentralize its diagnostics portfolio by integrating a multi-assay point-of-care platform that combines immunoassay and clinical chemistry testing on a single system. This move supports Roche’s strategic objective to expand access to rapid, near-patient diagnostics, particularly in primary care and low-resource settings. LumiraDx is a UK-based developer of a multi-assay point-of-care platform designed to deliver laboratory-quality results across immunoassay and clinical chemistry tests at the point of care.
Major companies operating in the automated immunoassay analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Tosoh Corporation, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd.
North America was the largest region in the automated immunoassay analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated immunoassay analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated immunoassay analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the automated immunoassay analyzers market by increasing costs for precision optical components, electronic modules, assay reagents, and instrument assemblies sourced across cross-border manufacturing networks. The impact is most significant in chemiluminescence and multiplexed assay systems, as well as analyzer production activities concentrated in Asia-Pacific and parts of Europe where component imports are tariff-sensitive. Hospitals, diagnostic laboratories, and pharmaceutical and biotechnology company end-user segments are facing higher procurement and installation costs due to elevated instrument pricing. However, tariffs are also encouraging regional assembly, localized reagent manufacturing, and strategic supplier diversification, which may strengthen supply resilience and stimulate domestic production capacity over time.
The automated immunoassay analyzers market research report is one of a series of new reports that provides automated immunoassay analyzers market statistics, including automated immunoassay analyzers industry global market size, regional shares, competitors with a automated immunoassay analyzers market share, detailed automated immunoassay analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the automated immunoassay analyzers industry. This automated immunoassay analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated immunoassay analyzers are sophisticated laboratory instruments designed to conduct immunoassays with minimal human input. These analyzers automate the detection and measurement of specific proteins, hormones, and other substances in biological samples, enhancing accuracy and efficiency in diagnostic testing. They are commonly used in clinical laboratories for disease diagnosis, monitoring, and research purposes.
The primary types of automated immunoassay analyzers include immunofluorescence, chemiluminescence, enzyme-linked immunosorbent assay (ELISA), multiplexed assay systems, and radioimmunoassay. Immunofluorescence is a technique that employs fluorescent-labeled antibodies to identify specific antigens in biological samples. These analyzers are applied in various fields, including infectious diseases, endocrinology, drug monitoring, cardiology, oncology, and allergy testing. They are utilized by hospitals, diagnostic laboratories, research and academic institutions, as well as pharmaceutical and biotechnology companies.
The automated immunoassay analyzers market consists of sales of sample handlers, reagents, incubation chambers, thermal printers, and wash stations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The automated immunoassay analyzers market size is expected to see rapid growth in the next few years. It will grow to $44.93 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to rising chronic and endocrine disorder testing needs, growing oncology and biomarker testing, demand for faster turnaround diagnostic results, increasing integration of automated platforms in research labs, expansion of pharmaceutical and biotech r&d testing applications. Major trends in the forecast period include growing demand for high-throughput diagnostic testing, increased adoption in infectious disease and endocrinology testing, expansion of automated testing in research and academic laboratories, rising utilization in therapeutic drug monitoring and oncology diagnostics, standardization of laboratory workflows to improve testing efficiency.
The increasing number of hospitals is expected to propel the growth of the automated immunoassay analyzers market going forward. Hospitals are healthcare institutions that provide medical, surgical, and diagnostic services to patients requiring routine treatment or emergency care, supported by specialized infrastructure and healthcare professionals. The global rise in the number of hospitals is driven by growing healthcare demand from expanding and aging populations, along with increased investments in healthcare infrastructure. Automated immunoassay analyzers support hospitals by enabling high-throughput, accurate, and rapid diagnostic testing for a wide range of diseases, improving clinical efficiency and patient outcomes. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the number of hospitals in the United States increased to 6,129 in 2023 from 6,093 in 2022, reflecting a 0.59% growth. Therefore, the increasing number of hospitals is driving the growth of the automated immunoassay analyzers market.
Leading companies in the automated immunoassay analyzer market are focusing on developing advanced products, such as compact immunoassay analyzers, to gain a competitive edge. These compact devices are designed for conducting immunoassay tests to detect specific biomarkers in biological samples and offer convenience and efficiency in various healthcare settings, especially where space and mobility are constraints. For instance, in July 2023, Siemens Healthineers, a Germany-based healthcare company, introduced the Atellica CI Analyzer. This compact system combines immunoassay and clinical chemistry testing into a single platform, addressing the growing demand for versatile and efficient testing solutions. The Atellica CI Analyzer features random access sampling, micro-volume aspiration, and automated maintenance and quality control scheduling to enhance the consistency and predictability of sample processing times.
In July 2024, Roche, a Switzerland-based provider of diagnostics, pharmaceutical products, and point-of-care testing solutions, acquired LumiraDx’s point-of-care technology for an undisclosed amount. With this acquisition, Roche aims to strengthen and decentralize its diagnostics portfolio by integrating a multi-assay point-of-care platform that combines immunoassay and clinical chemistry testing on a single system. This move supports Roche’s strategic objective to expand access to rapid, near-patient diagnostics, particularly in primary care and low-resource settings. LumiraDx is a UK-based developer of a multi-assay point-of-care platform designed to deliver laboratory-quality results across immunoassay and clinical chemistry tests at the point of care.
Major companies operating in the automated immunoassay analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Tosoh Corporation, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd.
North America was the largest region in the automated immunoassay analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated immunoassay analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated immunoassay analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the automated immunoassay analyzers market by increasing costs for precision optical components, electronic modules, assay reagents, and instrument assemblies sourced across cross-border manufacturing networks. The impact is most significant in chemiluminescence and multiplexed assay systems, as well as analyzer production activities concentrated in Asia-Pacific and parts of Europe where component imports are tariff-sensitive. Hospitals, diagnostic laboratories, and pharmaceutical and biotechnology company end-user segments are facing higher procurement and installation costs due to elevated instrument pricing. However, tariffs are also encouraging regional assembly, localized reagent manufacturing, and strategic supplier diversification, which may strengthen supply resilience and stimulate domestic production capacity over time.
The automated immunoassay analyzers market research report is one of a series of new reports that provides automated immunoassay analyzers market statistics, including automated immunoassay analyzers industry global market size, regional shares, competitors with a automated immunoassay analyzers market share, detailed automated immunoassay analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the automated immunoassay analyzers industry. This automated immunoassay analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Automated immunoassay analyzers are sophisticated laboratory instruments designed to conduct immunoassays with minimal human input. These analyzers automate the detection and measurement of specific proteins, hormones, and other substances in biological samples, enhancing accuracy and efficiency in diagnostic testing. They are commonly used in clinical laboratories for disease diagnosis, monitoring, and research purposes.
The primary types of automated immunoassay analyzers include immunofluorescence, chemiluminescence, enzyme-linked immunosorbent assay (ELISA), multiplexed assay systems, and radioimmunoassay. Immunofluorescence is a technique that employs fluorescent-labeled antibodies to identify specific antigens in biological samples. These analyzers are applied in various fields, including infectious diseases, endocrinology, drug monitoring, cardiology, oncology, and allergy testing. They are utilized by hospitals, diagnostic laboratories, research and academic institutions, as well as pharmaceutical and biotechnology companies.
The automated immunoassay analyzers market consists of sales of sample handlers, reagents, incubation chambers, thermal printers, and wash stations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Automated Immunoassay Analyzers Market Characteristics
3. Automated Immunoassay Analyzers Market Supply Chain Analysis
4. Global Automated Immunoassay Analyzers Market Trends and Strategies
5. Automated Immunoassay Analyzers Market Analysis of End Use Industries
7. Global Automated Immunoassay Analyzers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Automated Immunoassay Analyzers Total Addressable Market (TAM) Analysis for the Market
9. Automated Immunoassay Analyzers Market Segmentation
10. Automated Immunoassay Analyzers Market Regional and Country Analysis
11. Asia-Pacific Automated Immunoassay Analyzers Market
12. China Automated Immunoassay Analyzers Market
13. India Automated Immunoassay Analyzers Market
14. Japan Automated Immunoassay Analyzers Market
15. Australia Automated Immunoassay Analyzers Market
16. Indonesia Automated Immunoassay Analyzers Market
17. South Korea Automated Immunoassay Analyzers Market
18. Taiwan Automated Immunoassay Analyzers Market
19. South East Asia Automated Immunoassay Analyzers Market
20. Western Europe Automated Immunoassay Analyzers Market
21. UK Automated Immunoassay Analyzers Market
22. Germany Automated Immunoassay Analyzers Market
23. France Automated Immunoassay Analyzers Market
24. Italy Automated Immunoassay Analyzers Market
25. Spain Automated Immunoassay Analyzers Market
26. Eastern Europe Automated Immunoassay Analyzers Market
27. Russia Automated Immunoassay Analyzers Market
28. North America Automated Immunoassay Analyzers Market
29. USA Automated Immunoassay Analyzers Market
30. Canada Automated Immunoassay Analyzers Market
31. South America Automated Immunoassay Analyzers Market
32. Brazil Automated Immunoassay Analyzers Market
33. Middle East Automated Immunoassay Analyzers Market
34. Africa Automated Immunoassay Analyzers Market
36. Automated Immunoassay Analyzers Market Competitive Landscape and Company Profiles
37. Automated Immunoassay Analyzers Market Other Major and Innovative Companies
40. Automated Immunoassay Analyzers Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Automated Immunoassay Analyzers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses automated immunoassay analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for automated immunoassay analyzers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated immunoassay analyzers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Immunofluorescence; Chemiluminescence; Enzyme Linked Fluorescent System (ELISA); Multiplexed Assay System; Radioimmunoassay2) By Application: Infectious Diseases; Endocrinology; Drug Monitoring; Cardiology; Oncology; Allergy Testing; Other Applications
3) By End-User: Hospitals; Diagnostic Laboratories; Research And Academic Laboratories; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Immunofluorescence: Fluorescent Labeling Kits; Fluorescent Detectors And Readers; Immunofluorescence Reagents2) By Chemiluminescence: Chemiluminescent Labels And Reagents; Chemiluminescence Detectors And Readers; Chemiluminescent Assay Kits
3) By Enzyme Linked Fluorescent System (ELISA): ELISA Kits (Capture And Detection Kits); ELISA Microplates And Plates Coating Systems; Enzyme Substrates And Detection Reagents
4) By Multiplexed Assay System: Multiplexed Assay Kits; Multi-Analyte Detection Systems; Multiplexing Software And Data Analysis Tools
5) By Radioimmunoassay (RIA): Radioactive Isotope Kits; Gamma Counters; Radiolabeled Reagents
Companies Mentioned: Roche Diagnostics AG; Abbott Laboratories; Danaher Corporation; Siemens Healthineers; Becton Dickinson and Company; Tosoh Corporation; bioMérieux SA; QuidelOrtho Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc; Qiagen NV; Werfen Group SA; DiaSorin SpA; Bio-Techne Corporation; Meril Life Sciences Private Limited; Randox Laboratories Ltd; Getein Biotech Inc; Aesku Diagnostics GmbH & Co KG; Carolina Liquid Chemistries Corporation; Chengdu Seamaty Technology Co Ltd; Hipro Biotechnology Co Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Automated Immunoassay Analyzers market report include:- Roche Diagnostics AG
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers
- Becton Dickinson and Company
- Tosoh Corporation
- bioMérieux SA
- QuidelOrtho Corporation
- Sysmex Corporation
- Bio-Rad Laboratories Inc
- Qiagen NV
- Werfen Group SA
- DiaSorin SpA
- Bio-Techne Corporation
- Meril Life Sciences Private Limited
- Randox Laboratories Ltd
- Getein Biotech Inc
- Aesku Diagnostics GmbH & Co KG
- Carolina Liquid Chemistries Corporation
- Chengdu Seamaty Technology Co Ltd
- Hipro Biotechnology Co Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 26.39 Billion |
| Forecasted Market Value ( USD | $ 44.93 Billion |
| Compound Annual Growth Rate | 14.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
